全文获取类型
收费全文 | 4416篇 |
免费 | 277篇 |
国内免费 | 18篇 |
专业分类
耳鼻咽喉 | 33篇 |
儿科学 | 171篇 |
妇产科学 | 93篇 |
基础医学 | 720篇 |
口腔科学 | 62篇 |
临床医学 | 291篇 |
内科学 | 753篇 |
皮肤病学 | 62篇 |
神经病学 | 327篇 |
特种医学 | 81篇 |
外科学 | 470篇 |
综合类 | 146篇 |
一般理论 | 4篇 |
预防医学 | 364篇 |
眼科学 | 160篇 |
药学 | 520篇 |
中国医学 | 61篇 |
肿瘤学 | 393篇 |
出版年
2023年 | 25篇 |
2022年 | 27篇 |
2021年 | 85篇 |
2020年 | 87篇 |
2019年 | 100篇 |
2018年 | 123篇 |
2017年 | 88篇 |
2016年 | 99篇 |
2015年 | 129篇 |
2014年 | 159篇 |
2013年 | 249篇 |
2012年 | 333篇 |
2011年 | 351篇 |
2010年 | 217篇 |
2009年 | 148篇 |
2008年 | 247篇 |
2007年 | 223篇 |
2006年 | 265篇 |
2005年 | 211篇 |
2004年 | 177篇 |
2003年 | 142篇 |
2002年 | 146篇 |
2001年 | 98篇 |
2000年 | 104篇 |
1999年 | 62篇 |
1998年 | 35篇 |
1997年 | 22篇 |
1995年 | 19篇 |
1994年 | 18篇 |
1993年 | 15篇 |
1992年 | 54篇 |
1991年 | 55篇 |
1990年 | 42篇 |
1989年 | 56篇 |
1988年 | 38篇 |
1987年 | 31篇 |
1986年 | 27篇 |
1985年 | 35篇 |
1984年 | 27篇 |
1983年 | 30篇 |
1982年 | 14篇 |
1981年 | 14篇 |
1980年 | 17篇 |
1979年 | 31篇 |
1978年 | 17篇 |
1977年 | 21篇 |
1975年 | 16篇 |
1974年 | 17篇 |
1972年 | 15篇 |
1970年 | 13篇 |
排序方式: 共有4711条查询结果,搜索用时 62 毫秒
1.
2.
3.
Guru Sonpavde MD Neeraj Agarwal MD Gregory Russell Pond PhD Rebecca J. Nagy MSc Roberto H. Nussenzveig PhD Andrew W. Hahn MD Oliver Sartor MD Theodore Stewart Gourdin MD Lakshminarayanan Nandagopal MD Elisa M. Ledet PhD Gurudatta Naik MPH Andrew J. Armstrong MD MSc Jue Wang MD Mehmet Asim Bilen MD Shilpa Gupta MD Petros Grivas MD PhD Sumanta K. Pal MD Richard B. Lanman MD AmirAli Talasaz PhD Michael B. Lilly MD 《Cancer》2019,125(9):1459-1469
4.
Verbruggen Lisanne C. Hudson Melissa M. Bowers Daniel C. Ronckers Cécile M. Armstrong Gregory T. Skinner Roderick Hoving Eelco W. Janssens Geert O. van der Pal Helena J. H. Kremer Leontine C. M. Mulder Renée L. 《Journal of neuro-oncology》2020,147(2):417-425
Journal of Neuro-Oncology - Childhood, adolescent and young adult (CAYA) cancer survivors treated with cranial radiotherapy are at risk for developing subsequent meningiomas. There is insufficient... 相似文献
5.
Rimesh Pal Naresh Sachdeva Soham Mukherjee Vikas Suri Deepy Zohmangaihi Sant Ram Goverdhan Dutt Puri Ashish Bhalla Shiv Lal Soni Navin Pandey Anil Bhansali Sanjay Kumar Bhadada 《Diabetes & Metabolic Syndrome: Clinical Research & Reviews》2021,15(1):193-196
Background and aimsPatients with diabetes mellitus (DM) often demonstrate impaired antibody response to influenza/hepatitis B vaccines. Hence, we compared anti-SARS-CoV-2 antibody response in non-severe COVID-19 patients with and without type 2 diabetes mellitus (T2DM).MethodsRecords of non-severe COVID-19 patients admitted at our institution between April 10, 2020 and May 20, 2020 were retrieved. Qualitative detection of total (IgG + IgM) anti-SARS-CoV-2 antibody was performed using electrochemiluminescence immunoassay in plasma samples collected at least 14 days post-polymerase chain reaction (PCR) confirmation of diagnosis.ResultsThirty-one non-severe COVID-19 patients were included. Nine patients (29%) had T2DM with mean HbA1c at admission of 8.3 ± 1.0%. Anti-SARS-CoV-2 antibody was estimated at a median of 16 (14–17) days post-PCR confirmation of COVID-19 diagnosis. Only three patients (10%) were seronegative, and all had T2DM. Patients with T2DM were more likely to have non-detectable anti-SARS-CoV-2 antibodies than those without DM (p = 0.019).ConclusionsCOVID-19 patients with T2DM may not undergo seroconversion even after two weeks of diagnosis. Impaired seroconversion could theoretically increase the risk of reinfections in patients with DM. However, the finding requires validation in large-scale studies involving serial estimations of anti-SARS-CoV-2 antibodies in patients with and without DM. 相似文献
6.
7.
8.
Effects of vitamin D2 or D3 supplementation on glycaemic control and cardiometabolic risk among people at risk of type 2 diabetes: results of a randomized double‐blind placebo‐controlled trial 下载免费PDF全文
9.
Severe sepsis often leads to multiple organ dysfunction syndromes (MODS) with acute kidney injury (AKI). AKI affects approximately, 35% of Intensive Care Unit patients, and most of these are due to sepsis. Mortality rate of sepsis-induced AKI is high. Inappropriate use of antimicrobials may be responsible for higher therapeutic failure, mortality rates, costs and toxicity as well as the emergence of resistance. Antimicrobial treatment is particularly difficult due to altered pharmacokinetic profile, dynamic changes in patient''s clinical status and, in many cases, need for renal replacement therapy. This article aims to describe the appropriate antimicrobial dosing and reviews the factors contributing to the difficulties in establishing precise guidelines for antimicrobial dosing in sepsis-induced AKI patients. Search strategy: Text material was collected by systematic search in PubMed, Google (1978–2013) for original articles. 相似文献
10.
Benjamin R. Griffin J. Pedro Teixeira Sophia Ambruso Michael Bronsert Jay D. Pal Joseph C. Cleveland T. Brett Reece David A. Fullerton Sarah Faubel Muhammad Aftab 《The Journal of thoracic and cardiovascular surgery》2021,161(4):1346-1355.e3
ObjectivesSevere acute kidney injury (AKI) is a known risk factor for infection and mortality. However, whether stage 1 AKI is a risk factor for infection has not been evaluated in adults. We hypothesized that stage 1 AKI following cardiac surgery would independently associate with infection and mortality.MethodsIn this retrospective propensity score–matched study, we evaluated 1620 adult patients who underwent nonemergent cardiac surgery at the University of Colorado Hospital from 2011 to 2017. Patients who developed stage 1 AKI by Kidney Disease Improving Global Outcomes creatinine criteria within 72 hours of surgery were matched to patients who did not develop AKI. The primary outcome was an infection, defined as a new surgical-site infection, positive blood or urine culture, or development of pneumonia. Secondary outcomes included in-hospital mortality, stroke, and intensive care unit (ICU) and hospital length of stay (LOS).ResultsStage 1 AKI occurred in 293 patients (18.3%). Infection occurred in 20.9% of patients with stage 1 AKI compared with 8.1% in the no-AKI group (P < .001). In propensity-score matched analysis, stage 1 AKI independently associated with increased infection (odds ratio [OR]; 2.24, 95% confidence interval [CI], 1.37-3.17), ICU LOS (OR, 2.38; 95% CI, 1.71–3.31), and hospital LOS (OR, 1.30; 95% CI, 1.17-1.45).ConclusionsStage 1 AKI is independently associated with postoperative infection, ICU LOS, and hospital LOS. Treatment strategies focused on prevention, early recognition, and optimal medical management of AKI may decrease significant postoperative morbidity. 相似文献